Should medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? part I: framing the debate

By Barry M.J.   Fleming C.   Coley C.M.   Wasson J.H.   Fahs M.C.   Oesterling J.E.  

Urology, Vol. 46, Iss. 1, 1995-07 ,pp. : 2-13

Elsevier

Access to resources Recommend Favorite

Should medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part II: early detection strategies

By Coley C.M.   Barry M.J.   Fleming C.   Wasson J.H.   Fahs M.C.   Oesterling J.E.  

Urology, Vol. 46, Iss. 2, 1995-08 ,pp. : 125-141

Elsevier

Access to resources Recommend Favorite

Should medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part III: management strategies and outcomes

By Barry M.J.   Fleming C.   Coley C.M.   Wasson J.H.   Fahs M.C.   Oesterling J.E.  

Urology, Vol. 46, Iss. 3, 1995-09 ,pp. : 277-289

Elsevier

Access to resources Recommend Favorite

Serum prostate-specific antigen and digital rectal examination for early detection of prostate cancer in a national community-based program

By Crawford E.D.   DeAntoni E.P.   Etzioni R.   Schaefer V.C.   Olson R.M.   Ross C.A.  

Urology, Vol. 47, Iss. 6, 1996-06 ,pp. : 863-869

Elsevier

Access to resources Recommend Favorite

Prostate-specific antigen best practice policy-part I: early detection and diagnosis of prostate cancer

By Carroll P.   Coley C.   McLeod D.   Schellhammer P.   Sweat G.   Wasson J.   Zietman A.   Thompson I.  

Urology, Vol. 57, Iss. 2, 2001-02 ,pp. : 217-224

Elsevier

Access to resources Recommend Favorite